SCHEMBL7655071

SCHEMBL7655071

CCOc1ccc(NNc2[c]cccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.44
LTA4H P09960 1/20 0.43
MAPT P10636 4/20 0.42
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
POLB P06746 4/20 0.41
LMNA P02545 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP1A2 P05177 1/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
KDM4E B2RXH2 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
RAD52 P43351 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HTT P42858 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8725862 0.86 MAPT (0.49) NQO1LTA4HMAPTKMT2AMEN1
SCHEMBL8325875 0.79 NQO1 (0.70) NQO1LTA4HMAPTKMT2AMEN1
SCHEMBL6414564 0.75 ALDH1A1 (0.55) MAPTKMT2AMEN1LMNATDP1
SCHEMBL3735038 0.73 NQO1 (0.50) NQO1LTA4HMAPTKMT2AMEN1
SCHEMBL15009704 0.70 LTA4H (0.58) NQO1LTA4HMAPTKMT2AMEN1
SCHEMBL9062221 0.70 SMN1; SMN2 (0.51) NQO1LTA4HMAPTKMT2AMEN1
SCHEMBL8721612 0.70 BRAF (0.38) MAPTKMT2AMEN1LMNATDP1
SCHEMBL3440767 0.69 MAPT (0.63) NQO1LTA4HMAPTKMT2AMEN1
SCHEMBL9479637 0.69 MAPT (0.63) NQO1LTA4HMAPTKMT2AMEN1
SCHEMBL7785326 0.68 NQO1 (0.47) NQO1LTA4HMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462076-B2 CYSTEINE PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CYSTEINE PROTEASES, SUCH AS OSTEOPOROSIS, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, TUMOR METASTASIS, ANGINA PECTORIS, PLAQUE RUPTURE AND STROKE ETC. HOFFMANN-LA ROCHE INC. 2002-10-08 US disclosed